Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014;15(2):e72-9. 5 Adatya S, Uriel N, Yarmohammadi H, Holley CT, Feng A, Roy SS, ...
The INNOVANCE Anti-Xa assay is an automated chromogenic assay for the quantitative determination of the activity of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) as well as rivaroxaban1, apixaban and edoxaban1 concentrations in citrated human plasma. The INNOVANCE Anti-Xa assa...
Anti-factor Xa assay: an effec- tive method to determine the appropriate dose of heparin in pregnant women. Clin Appl Thromb Hemost 2008; 14(1):118-119.Vineeta S, Ved Prakash C, Renu S. Anti-factor Xa Assay: an effective method to determine the appropriate dose of heparin in pregnant ...
Antifactor Xa Assay Heparin Antifactor Xa AssayHeparin Antifactor Xa AssayTime, Activated ClottingPartial, ActivatedTime, ThromboplastinNeutralization, HeparinTime, ThrombinAntifactor, SynonymsAssay, XaAssay, AntixaAssay, Heparin
精准监测之Anti-Xa 精准监测之Anti-Xa 抗Xa活性测定，可针对临床上广泛用于预防和治疗血栓性疾病的抗凝血药物—普通肝素和低分子肝素的药效进行监测，较传统的实验室监测方法APTT，抗Xa活性测定方法更为特异，检测结果稳定，可以更真实地体现病人体内的抗凝效果。本文参考相关国内外文献及临床指南/共识，对肝素监测的两...
In order to adapt the anti-factor Xa assay for the microfluidic chip, a florescence probe was selected, which greatly enhance the robustness of the measurement using small sample volume. The real-time monitoring of anti-factor Xa level was demonstrated in rats receiving LMWH for 7 hours. The ...
抗xa因子活性测定在长期血液透析老年患者应用-application of determination of anti - xa factor activity in elderly patient undergoing long-term hemodialysis.docx,2.低分子肝素组与普通肝素组老年患者抗 Xa 因子活性分别为(0.643±0.583)IU/ml、(0.550±0.273)IU
Anti-FXa Anti-factor Xa heparin assayAPTT Activated partial thromboplastin timeCRNMB Clinically relevant nonmajor bleedingECMO Extracorporeal membrane oxygenationHIT Heparin-induced thrombocytopeniaLVAD Left ventricular assist deviceTo assess clinical outcomes in children treated with unfractionated heparin and ...
Test of the month: the chromogenic antifactor Xa assay. Am J Hematol. 2012;87:194–6. Article CAS PubMed Google Scholar Yoshida K, Wada H, Hasegawa M, Wakabayashi H, Ando H, Oshima S, et al. Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients ...
Test of the month: the chromogenic antifactor Xa assay. Am J Hematol. 2012;87:194–6. Article CAS PubMed Google Scholar Yoshida K, Wada H, Hasegawa M, Wakabayashi H, Ando H, Oshima S, et al. Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients ...